SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
BioPharm Executive: 5 Reasons To Hate Biotech
Biotech Beach
BioPharm Executive: Top 6 Things The Life Sciences Has To Be Thankful For
November 24, 2014
 · 
5 min read
Lone Star Bio
For Women, Job Authority Adds To Depression Symptoms, University of Texas Study
November 21, 2014
 · 
2 min read
Lone Star Bio
Genteel Lancing Device For Pain-Free Glucose Testing Anywhere On Body
November 20, 2014
 · 
1 min read
Genetown
Injectable Treatment To Prevent Blood Loss From Serious Internal Injuries, Texas A&M University Study
November 19, 2014
 · 
1 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Deals
Cancer Biotech Bellicum Pharmaceuticals, Inc. Files For $115 Million IPO
November 19, 2014
 · 
2 min read
Top 10 Countries for Diabetes Clinical Research
Biotech Bay
Top 10 Countries For Diabetes Clinical Research
November 19, 2014
 · 
6 min read
The Growing Presence of Biotech in the World of Social Media
Biotech Bay
The Growing Presence Of Biotech In The World Of Social Media
November 19, 2014
 · 
3 min read
Lone Star Bio
Explosive Compound May Reduce Blood Pressure, Johannes Gutenberg University Study
November 11, 2014
 · 
2 min read
Lone Star Bio
Marijuana’s Long-Term Effects On The Brain, University Of Texas At Dallas Study
November 11, 2014
 · 
3 min read
The 10 Best Cities for Single Biotech Professionals
BioCapital
The 10 Best Cities For Single Biotech Professionals
November 4, 2014
 · 
5 min read
Load More
PRESS RELEASES
Press Releases
FibroBiologics Announces up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
June 26, 2026
 · 
6 min read
Press Releases
Medicenna Therapeutics Reports Fiscal Year 2026 Financial Results and Operational Highlights
June 26, 2026
 · 
11 min read
Press Releases
DecisionDx®-Melanoma’s i31-SLNB Outperforms MIA Nomogram in Identifying Patients Who May Safely Forgo Sentinel Lymph Node Biopsy
June 25, 2026
 · 
10 min read
Press Releases
Taysha Gene Therapies Announces Multiple Presentations Highlighting its TSHA-102 Clinical Program at the 2026 IRSF Rett Syndrome Scientific Meeting
June 25, 2026
 · 
7 min read
Press Releases
Natera and Eledon Announce Strategic Partnership for Prospera™ Monitoring in Planned Phase 3 Kidney Transplant Trial
June 25, 2026
 · 
8 min read
Press Releases
Plus Therapeutics Secures National Coverage Agreement with Elevance Health for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
June 25, 2026
 · 
3 min read
Press Releases
Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
June 25, 2026
 · 
5 min read
Press Releases
Ollin Biosciences Announces Oversubscribed $330 Million Series B Financing to Advance Global Phase 3 Development of OLN324 in DME and Wet AMD; Studies Commencing in Second Half of 2026
June 24, 2026
 · 
5 min read
Press Releases
Signatera™ Receives Regulatory Approval in Japan for Colorectal Cancer
June 24, 2026
 · 
5 min read
Press Releases
Susan G. Komen® Awards $15.4 Million In Research Grants to Accelerate Breakthroughs in Breast Cancer Care
June 24, 2026
 · 
6 min read
Load More